The U.S. Sucralfate Market Gains Traction Driven by Increasing Ulcer Treatment Procedures
![]() |
U.S. Sucralfate Market |
The
U.S. sucralfate market offers products that protect ulcers in the esophagus,
stomach and small intestine from further damage. Sucralfate aids in ulcer
healing by forming a protective covering over the ulcer which helps in
preventing further injury to the lining of the digestive tract. The demand for
sucralfate is rising owing to increasing incidence of ulcers caused by stress,
medication intake and lifestyle changes.
The
Global U.S. Sucralfate Market is estimated to be valued at US$ 70.05 Mn in 2024
and is expected to exhibit a CAGR of 5.6% over the forecast period 2024 to
2030.
Key Takeaways
Key players operating in the Global
U.S. Sucralfate Market Demand are Pfizer Inc., Merck & Co., Inc.,
GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Johnson & Johnson, Abbott
Laboratories, Eli Lilly and Company, AstraZeneca plc, Bayer AG, Bristol-Myers
Squibb Company, Roche Holding AG, Teva Pharmaceutical Industries Ltd., Mylan
N.V., Allergan plc.
The growing demand for ulcer treatment drugs across the United States is a
major factor fueling the growth of the sucralfate market. The increasing number
of prescriptions for nonsteroidal anti-inflammatory drugs and other medications
that may cause gastrointestinal ulcers has augmented the demand for sucralfate
products.
Geographic expansion of key players into new territories and acquisitions &
partnerships with regional pharmaceutical players to bolster product access
across the US healthcare setup is expected to drive the sucralfate market
growth over the forecast period.
Market key trends
One of the key trends witnessed in the US sucralfate market is the introduction
of sucralfate in new oral formulations and delivery forms for enhancing patient
compliance. Several manufacturers are engaged in developing sucralfate tablets
and effervescent granule formulations that ensure improved and faster drug
delivery. This is anticipated to positively impact the adoption of sucralfate
products among patients and healthcare practitioners.
Porter’s Analysis
Threat of new entrants: High capital requirements and stringent regulations
from FDA act as entry barriers.
Bargaining
power of buyers: Buyers have medium bargaining power as sucralfate drugs are
often substitutes for each other and can easily switch to alternative drugs
available.
Bargaining
power of suppliers: Suppliers have medium to low bargaining power due to
availability of substitute raw materials and active pharmaceutical ingredients.
Threat
of new substitutes: Few alternatives exist but they may gain market share in
future due to perceived advantages.
Competitive
rivalry: Strong as major players compete on basis of price and brand value.
Geographical Regions
The United States accounts for largest share of sucralfate market value
currently. High prevalence of gastric ulcers and frequent prescription of
sucralfate drugs majorly contribute to this concentration.
Asia Pacific region is expected to be fastest growing for sucralfate market
during forecast period. Rising geriatric population, improving access to
healthcare facilities and growing medical tourism are key factors fueling the
demand. Countries like India, China and Japan are expected to be high potential
markets.
Get more insights on this topic: U.S.
Sucralfate Market
Comments
Post a Comment